No icon

Passion IT Framework

MAPK4 Presents Novel Therapeutic Target for Treatment of Triple-Negative Breast Cancer

With new evidence demonstrating the involvement of the MAPK4 enzyme in cancer growth and therapy resistance, researchers believe the enzyme plays an important role in triple-negative breast cancer (TNBC).

Read More at:

https://www.pharmacytimes.com/view/mapk4-presents-novel-therapeutic-target-for-treatment-of-triple-negative-breast-cancer

Comment